Clinical Trial Update: A Single-Patient Study Using AGS 006 [NA]

View source ↗

Summary

This document reports the completion of a single-patient clinical trial evaluating AGS-006 for pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AGS-006 (AGS-006 autologous dendritic cell vaccine)

Snippet

Sponsor: Argos Therapeutics | Conditions: Pancreatic Cancer | NA | Status: COMPLETED